Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologic directed therapies in gynecologic oncology.

Current oncology reports - 1 Nov 2003

Farley John H, Birrer Michael J

Abstract excerpt

Evaluation of the genome has provided information concerning the origins of many human diseases, including cancer. Identification of the genes and their protein products has greatly increased our understanding of this complex disease. A variety of cellular processes and pathways stimulate cellular proliferation or inhibit cell death. Many of these pathways are targets for novel therapeutic agents. These agents...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Death
Share to Cell Division
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genital Neoplasms, Female

Share to Medical Oncology

Share to Women's Health

Source

Identifiers

PMID: 14521804
DOI: 10.1007/s11912-003-0006-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologic directed therapies in gynecologic oncology.PMID 14521804Read ↗

Biologic therapies and personalized medicine in gynecologic malignancies.Semantic proximity Read ↗

Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.Semantic proximity Read ↗

Overview of targeted therapies for cancerSemantic proximity Read ↗

Molecular/genetic therapies in ovarian cancer: future opportunities and challenges.Semantic proximity Read ↗

Novel strategies for therapeutic design in molecular oncology using gene expression profiles.Semantic proximity Read ↗

Targeting the Cell Cycle: A New Approach to Cancer TherapySemantic proximity Read ↗

Development of Cell Cycle Active Drugs for the Treatment of Gastrointestinal Cancers: A New Approach to Cancer TherapySemantic proximity Read ↗

Cancer Therapy: Targeting Cell Cycle RegulatorsSemantic proximity Read ↗

Selected novel anticancer treatments targeting cell signaling proteins.Semantic proximity Read ↗

Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53Semantic proximity Read ↗

Anticancer Effects of Mifepristone on Human Uveal Melanoma CellsSemantic proximity Read ↗

Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.